Results 141 to 150 of about 59,004 (282)

Pneumomediastinum and Pneumopericardium in Rapidly Progressive Interstitial Lung Disease Secondary to Anti‐MDA5 Dermatomyositis

open access: yesClinical Case Reports
Anti‐melanoma differentiation associated protein 5 antibody positive dermatomyositis (anti‐MDA5 dermatomyositis) is characterized by rapidly progressive interstitial lung disease and skin involvement with a paucity of muscle involvement.
Thomas Bond   +3 more
doaj   +1 more source

Cell-free DNA profiles of dermatomyositis and its potential role in discriminating phenotypes

open access: yesFrontiers in Immunology
BackgroundCell-free DNA (cfDNA) functions in the early-detection and monitoring of autoimmune diseases including systemic lupus erythematosus and rheumatoid arthritis.
Zhuang-li Tang   +11 more
doaj   +1 more source

Dermatomyositis [PDF]

open access: yesProceedings of the Royal Society of Medicine, 1939
S, Behrman, L, Forman
openaire   +2 more sources

[Juvenile dermatomyositis].

open access: yesLa Pediatria medica e chirurgica : Medical and surgical pediatrics, 1990
Juvenile dermatomyositis (JDM) is a chronic multisystem inflammatory disease that primarily involves skin and muscles. The clinical picture is mainly characterized by the typical cutaneous rash and by skeletal muscle weakness. Nevertheless the vasculitic process may extend in some cases to other organs such as lung, joints or gastrointestinal system ...
MARTINI, ALBERTO   +3 more
openaire   +2 more sources

Dermatomyositis [PDF]

open access: yesProceedings of the Royal Society of Medicine, 1953
openaire   +3 more sources

Dermatomyositis as an initial presentation of underlying breast malignancy: a paraneoplastic manifestation

open access: yesAsian Journal of Internal Medicine
Though dermatomyositis is a well-known paraneoplastic syndrome, its particular relationship with breast cancer is yet to be thoroughly defined and there are no established guidelines for the treatment.
A. Pakeerathan   +4 more
doaj   +1 more source

Dermatomyositis [PDF]

open access: yesProceedings of the Royal Society of Medicine, 1932
J H, Sheldon, W, Sheldon
openaire   +2 more sources

Rituximab in the treatment of inflammatory myopathies: a review [PDF]

open access: yes, 2017
Several uncontrolled studies have encouraged the use of rituximab (RTX) in patients with myositis. Unfortunately, the first placebo-phase trial to assess the efficacy of RTX in refractory myositis did not show a significant difference between the two ...
Fasano, S   +4 more
core  

Dermatomyositis [PDF]

open access: yesProceedings of the Royal Society of Medicine, 1936
openaire   +2 more sources

Dermatomyositis [PDF]

open access: yesProceedings of the Royal Society of Medicine, 1957
openaire   +2 more sources

Home - About - Disclaimer - Privacy